In addition, the extracellular region of Muc1 contains the KL-6 epitope, which is proposed to be a useful biomarker for evaluating disease activity and predicting clinical outcomes in IPF [154]. This evidence concerns the gene MUC1 and idiopathic pulmonary fibrosis.